This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-consensus: Archive
Does Nexxen International Ltd. Sponsored ADR (NEXN) Have the Potential to Rally 53.34% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 53.3% in Nexxen International Ltd. Sponsored ADR (NEXN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
NEXNPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe ARKO (ARKO) Could Rally 32.6%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 32.6% upside potential for ARKO (ARKO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ARKONo Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Arcutis Biotherapeutics (ARQT) Have the Potential to Rally 45.81% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 45.8% in Arcutis Biotherapeutics (ARQT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
ARQTNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Predict a 41.36% Upside in CI&T (CINT): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 41.4% upside potential for CI&T (CINT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
CINTPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Predict a 130.63% Upside in Foghorn Therapeutics (FHTX): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for Foghorn Therapeutics (FHTX) points to a 130.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
FHTXNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe DoubleDown Interactive (DDI) Could Rally 99.48%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 99.5% upside potential for DoubleDown Interactive (DDI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
DDINegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Predict a 35.8% Upside in Ranpak Holdings (PACK): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for Ranpak Holdings (PACK) points to a 35.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
PACKPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Amneal (AMRX) Could Surge 25.52%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 25.5% upside potential for Amneal (AMRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
AMRXNo Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does BioLife Solutions (BLFS) Have the Potential to Rally 25.6% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 25.6% upside potential for BioLife Solutions (BLFS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
BLFSNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Adeia (ADEA) Could Surge 27.58%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for Adeia (ADEA) points to a 27.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ADEAPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Beyond (BYON) Could Surge 59.75%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for Beyond (BYON) points to a 59.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Alkami (ALKT) Could Surge 50.64%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 50.6% upside potential for Alkami (ALKT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ALKTPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts See an 115.23% Upside in Xperi (XPER): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Xperi (XPER) points to an 115.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
XPERPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Predict a 33.1% Upside in Potbelly (PBPB): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 33.1% upside potential for Potbelly (PBPB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
How Much Upside is Left in Globale Online (GLBE)? Wall Street Analysts Think 36.83%
by Zacks Equity Research
The mean of analysts' price targets for Globale Online (GLBE) points to a 36.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
GLBEPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
How Much Upside is Left in Inventiva (IVA)? Wall Street Analysts Think 100.79%
by Zacks Equity Research
The mean of analysts' price targets for Inventiva (IVA) points to a 100.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
IVANegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at a 98.6% upside potential for Anika (ANIK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ANIKPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Earnings Preview: Shoe Carnival (SCVL) Q2 Earnings Expected to Decline
by Zacks Equity Research
Shoe Carnival (SCVL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SCVLNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Torrid Holdings (CURV) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Torrid Holdings (CURV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CURVPositive Net Change AEOPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Analysts Estimate Lululemon (LULU) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Lululemon (LULU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LULUPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Does Electromed (ELMD) Have the Potential to Rally 38.6% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Electromed (ELMD) points to a 38.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ELMDPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does AxoGen (AXGN) Have the Potential to Rally 53.1% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for AxoGen (AXGN) points to a 53.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
AXGNPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think SunOpta (STKL) Could Surge 57.73%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 57.7% upside potential for SunOpta (STKL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
STKLPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe VAREX IMAGING (VREX) Could Rally 46.29%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 46.3% upside potential for VAREX IMAGING (VREX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
VREXNo Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Peloton (PTON) Could Rally 34.77%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 34.8% upside potential for Peloton (PTON). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
PTONPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate